♻ 2020FDA approves first drug for Alexander disease, a rare genetic brain disorder.

"FDA approves first drug targeting Alexander disease" — Science Daily (all) · Science & Medicine

13 Oct 2026

What it means

The FDA has approved Zanvastro (zilganersen), the first drug to treat , a rare and devastating genetic brain disorder. This is an therapy that directly targets the underlying protein buildup () driving the disease, rather than just managing symptoms, and is given as a quarterly .

Accuracy & sourcesGrounded

The claim is solid and directly reflects the FDA's official press announcement, which is the primary source. The reporting from Science Daily and other outlets closely mirrors the FDA's language and adds context from the pivotal trial data, so the accuracy is high.

♻ 2020FDA approves first drug for Alexander disease, a rare genetic brain disorder.

What it means

Accuracy & sourcesGrounded

How new